Log in

NASDAQ:APDNApplied DNA Sciences Stock Price, Forecast & News

$9.64
-0.23 (-2.33 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.41
Now: $9.64
$10.06
50-Day Range
$3.98
MA: $8.44
$15.21
52-Week Range
$2.52
Now: $9.64
$26.80
Volume284,759 shs
Average Volume2.17 million shs
Market Capitalization$45.12 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95
Applied DNA Sciences, Inc. develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, Smart DNA, and Backtrac that are molecular tags to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high-value assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers that provides real-time authentication of molecular tags. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems and Cannabis Tracking System, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services for the nucleic acid-based medical and biologic markets; and various RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Read More
Applied DNA Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous business services
Sub-IndustryN/A
SectorIndustrial Products
Current SymbolNASDAQ:APDN
CUSIPN/A
Phone631-840-8800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.39 million
Book Value($0.71) per share

Profitability

Net Income$-8,620,000.00
Net Margins-167.84%

Miscellaneous

Employees59
Market Cap$45.12 million
Next Earnings Date8/11/2020 (Estimated)
OptionableOptionable

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

How has Applied DNA Sciences' stock been impacted by COVID-19 (Coronavirus)?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, APDN shares have increased by 135.1% and is now trading at $9.64. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Applied DNA Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Applied DNA Sciences.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Applied DNA Sciences.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences Inc (NASDAQ:APDN) announced its quarterly earnings results on Thursday, May, 14th. The technology company reported ($0.79) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.77) by $0.02. The technology company had revenue of $0.55 million for the quarter. Applied DNA Sciences had a negative return on equity of 279.79% and a negative net margin of 167.84%. View Applied DNA Sciences' earnings history.

What price target have analysts set for APDN?

1 equities research analysts have issued 12-month price targets for Applied DNA Sciences' shares. Their forecasts range from $21.00 to $21.00. On average, they anticipate Applied DNA Sciences' stock price to reach $21.00 in the next year. This suggests a possible upside of 117.8% from the stock's current price. View analysts' price targets for Applied DNA Sciences.

Has Applied DNA Sciences been receiving favorable news coverage?

News articles about APDN stock have trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Applied DNA Sciences earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutApplied DNA Sciences.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 182,300 shares, an increase of 145.0% from the April 30th total of 74,400 shares. Based on an average daily trading volume, of 1,810,000 shares, the short-interest ratio is presently 0.1 days. Currently, 6.1% of the company's stock are sold short. View Applied DNA Sciences' Current Options Chain.

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Ekso Bionics (EKSO), TerraForm Global (GLBL), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Micron Technology (MU), Anavex Life Sciences (AVXL), Intel (INTC), SCYNEXIS (SCYX) and VBI Vaccines (VBIV).

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • Dr. James A. Hayward Ph.D., Sc.D., Pres, CEO & Chairman (Age 65)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 43)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 61)
  • Mr. Clay Shorrock Esq., Gen. Counsel
  • Mr. Tony Benson, Managing Director of EMEA

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a number of retail and institutional investors. Top institutional investors include Morgan Stanley (1.71%) and Sabby Management LLC (0.76%). View institutional ownership trends for Applied DNA Sciences.

Which institutional investors are buying Applied DNA Sciences stock?

APDN stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, and Sabby Management LLC. View insider buying and selling activity for Applied DNA Sciences.

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $9.64.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $45.12 million and generates $5.39 million in revenue each year. Applied DNA Sciences employs 59 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.